Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 230 entries
Sorted by: Best Match Show Resources per page
Evolving with contemporary contract research.

Nature reviews. Drug discovery

Chapman I.
PMID: 12841192
Nat Rev Drug Discov. 2003 Jul;2(7):597. doi: 10.1038/nrd1137.

No abstract available.

Cite
Chapman I. Evolving with contemporary contract research. Nat Rev Drug Discov. 2003;2(7):597doi: 10.1038/nrd1137.
Chapman, I. (2003). Evolving with contemporary contract research. Nature reviews. Drug discovery, 2(7), 597. https://doi.org/10.1038/nrd1137
Chapman, Ian. "Evolving with contemporary contract research." Nature reviews. Drug discovery vol. 2,7 (2003): 597. doi: https://doi.org/10.1038/nrd1137
Chapman I. Evolving with contemporary contract research. Nat Rev Drug Discov. 2003 Jul;2(7):597. doi: 10.1038/nrd1137. PMID: 12841192.
Copy Download .nbib Format: NLM
Collaboration may be the cure for what ails drug development.

Nature medicine

Erickson AK.
PMID: 15170189
Nat Med. 2004 Jun;10(6):558. doi: 10.1038/nm0604-558b.

No abstract available.

Cite
Erickson AK. Collaboration may be the cure for what ails drug development. Nat Med. 2004;10(6):558doi: 10.1038/nm0604-558b.
Erickson, A. K. (2004). Collaboration may be the cure for what ails drug development. Nature medicine, 10(6), 558. https://doi.org/10.1038/nm0604-558b
Erickson, Amy K. "Collaboration may be the cure for what ails drug development." Nature medicine vol. 10,6 (2004): 558. doi: https://doi.org/10.1038/nm0604-558b
Erickson AK. Collaboration may be the cure for what ails drug development. Nat Med. 2004 Jun;10(6):558. doi: 10.1038/nm0604-558b. PMID: 15170189.
Copy Download .nbib Format: NLM
Intelligent risk communication: can it be improved?.

Drug safety

Czarnecki A.
PMID: 18095742
Drug Saf. 2008;31(1):1-6. doi: 10.2165/00002018-200831010-00001.

Every year, regulators and scientists from academia and industry invest considerable time and effort into drug development, the assessment of safety, and subsequent risk-benefit communication. The observation of everyday medical practice, lay press releases and drug information indicates that...

Cite
Czarnecki A. Intelligent risk communication: can it be improved?. Drug Saf. 2008;31(1):1-6doi: 10.2165/00002018-200831010-00001.
Czarnecki, A. (2008). Intelligent risk communication: can it be improved?. Drug safety, 31(1), 1-6. https://doi.org/10.2165/00002018-200831010-00001
Czarnecki, Andrzej. "Intelligent risk communication: can it be improved?." Drug safety vol. 31,1 (2008): 1-6. doi: https://doi.org/10.2165/00002018-200831010-00001
Czarnecki A. Intelligent risk communication: can it be improved?. Drug Saf. 2008;31(1):1-6. doi: 10.2165/00002018-200831010-00001. PMID: 18095742.
Copy Download .nbib Format: NLM
Drug discovery through industry-academic partnerships.

Nature chemical biology

Gray NS.
PMID: 17108976
Nat Chem Biol. 2006 Dec;2(12):649-53. doi: 10.1038/nchembio1206-649.

No abstract available.

Cite
Gray NS. Drug discovery through industry-academic partnerships. Nat Chem Biol. 2006;2(12):649-53doi: 10.1038/nchembio1206-649.
Gray, N. S. (2006). Drug discovery through industry-academic partnerships. Nature chemical biology, 2(12), 649-53. https://doi.org/10.1038/nchembio1206-649
Gray, Nathanael S. "Drug discovery through industry-academic partnerships." Nature chemical biology vol. 2,12 (2006): 649-53. doi: https://doi.org/10.1038/nchembio1206-649
Gray NS. Drug discovery through industry-academic partnerships. Nat Chem Biol. 2006 Dec;2(12):649-53. doi: 10.1038/nchembio1206-649. PMID: 17108976.
Copy Download .nbib Format: NLM
Similarity-based virtual screening using 2D fingerprints.

Drug discovery today

Willett P.
PMID: 17129822
Drug Discov Today. 2006 Dec;11(23):1046-53. doi: 10.1016/j.drudis.2006.10.005. Epub 2006 Oct 20.

This paper summarizes recent work at the University of Sheffield on virtual screening methods that use 2D fingerprint measures of structural similarity. A detailed comparison of a large number of similarity coefficients demonstrates that the well-known Tanimoto coefficient remains...

Cite
Willett P. Similarity-based virtual screening using 2D fingerprints. Drug Discov Today. 2006;11(23):1046-53doi: 10.1016/j.drudis.2006.10.005.
Willett, P. (2006). Similarity-based virtual screening using 2D fingerprints. Drug discovery today, 11(23), 1046-53. https://doi.org/10.1016/j.drudis.2006.10.005
Willett, Peter. "Similarity-based virtual screening using 2D fingerprints." Drug discovery today vol. 11,23 (2006): 1046-53. doi: https://doi.org/10.1016/j.drudis.2006.10.005
Willett P. Similarity-based virtual screening using 2D fingerprints. Drug Discov Today. 2006 Dec;11(23):1046-53. doi: 10.1016/j.drudis.2006.10.005. Epub 2006 Oct 20. PMID: 17129822.
Copy Download .nbib Format: NLM
Collection and preparation of molecular databases for virtual screening.

SAR and QSAR in environmental research

Saxena AK, Prathipati P.
PMID: 16920660
SAR QSAR Environ Res. 2006 Aug;17(4):371-92. doi: 10.1080/10629360600884462.

Drug discovery and development research is undergoing a paradigm shift from a linear and sequential nature of the various steps involved in the drug discovery process of the past to the more parallel approach of the present, due to...

Cite
Saxena AK, Prathipati P. Collection and preparation of molecular databases for virtual screening. SAR QSAR Environ Res. 2006;17(4):371-92doi: 10.1080/10629360600884462.
Saxena, A. K., & Prathipati, P. (2006). Collection and preparation of molecular databases for virtual screening. SAR and QSAR in environmental research, 17(4), 371-92. https://doi.org/10.1080/10629360600884462
Saxena, A K, and Prathipati, P. "Collection and preparation of molecular databases for virtual screening." SAR and QSAR in environmental research vol. 17,4 (2006): 371-92. doi: https://doi.org/10.1080/10629360600884462
Saxena AK, Prathipati P. Collection and preparation of molecular databases for virtual screening. SAR QSAR Environ Res. 2006 Aug;17(4):371-92. doi: 10.1080/10629360600884462. PMID: 16920660.
Copy Download .nbib Format: NLM
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, Morrison-Bogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL, Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ.
PMID: 18631960
Alzheimers Dement. 2008 May;4(3):156-63. doi: 10.1016/j.jalz.2008.03.005.

No abstract available.

Cite
Khachaturian ZS, Petersen RC, Gauthier S, et al. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement. 2008;4(3):156-63doi: 10.1016/j.jalz.2008.03.005.
Khachaturian, Z. S., Petersen, R. C., Gauthier, S., Buckholtz, N., Corey-Bloom, J. P., Evans, B., Fillit, H., Foster, N., Greenberg, B., Grundman, M., Sano, M., Simpkins, J., Schneider, L. S., Weiner, M. W., Galasko, D., Hyman, B., Kuller, L., Schenk, D., Snyder, S., Thomas, R. G., Tuszynski, M. H., Vellas, B., Wurtman, R. J., Snyder, P. J., Frank, R. A., Albert, M., Doody, R., Ferris, S., Kaye, J., Koo, E., Morrison-Bogorad, M., Reisberg, B., Salmon, D. P., Gilman, S., Mohs, R., Aisen, P. S., Breitner, J. C., Cummings, J. L., Kawas, C., Phelps, C., Poirier, J., Sabbagh, M., Touchon, J., Khachaturian, A. S., & Bain, L. J. (2008). A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimer's & dementia : the journal of the Alzheimer's Association, 4(3), 156-63. https://doi.org/10.1016/j.jalz.2008.03.005
Khachaturian, Zaven S, et al. "A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. 4,3 (2008): 156-63. doi: https://doi.org/10.1016/j.jalz.2008.03.005
Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, Morrison-Bogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL, Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement. 2008 May;4(3):156-63. doi: 10.1016/j.jalz.2008.03.005. PMID: 18631960; PMCID: PMC2544623.
Copy Download .nbib Format: NLM
Medicines for the world: a way forward.

AIDS treatment news

James JS.
PMID: 15199870
AIDS Treat News. 2004 Mar 26;(399):7-8.

For poor and middle-income countries we should negotiate large sales involving many countries, with all the interests at the table. Large deals and public consensus could make it viable for companies to develop treatments for diseases affecting poor regions.

Cite
James JS. Medicines for the world: a way forward. AIDS Treat News. 2004;(399):7-8
James, J. S. (2004). Medicines for the world: a way forward. AIDS treatment news, (399), 7-8.
James, John S. "Medicines for the world: a way forward." AIDS treatment news vol. ,399 (2004): 7-8.
James JS. Medicines for the world: a way forward. AIDS Treat News. 2004 Mar 26;(399):7-8. PMID: 15199870.
Copy Download .nbib Format: NLM
Speed dating for molecules CombinatoRx looks for that special synergy.

Chemistry & biology

Wolfson W.
PMID: 16720264
Chem Biol. 2006 May;13(5):461-2. doi: 10.1016/j.chembiol.2006.05.003.

No abstract available.

Cite
Wolfson W. Speed dating for molecules CombinatoRx looks for that special synergy. Chem Biol. 2006;13(5):461-2doi: 10.1016/j.chembiol.2006.05.003.
Wolfson, W. (2006). Speed dating for molecules CombinatoRx looks for that special synergy. Chemistry & biology, 13(5), 461-2. https://doi.org/10.1016/j.chembiol.2006.05.003
Wolfson, Wendy. "Speed dating for molecules CombinatoRx looks for that special synergy." Chemistry & biology vol. 13,5 (2006): 461-2. doi: https://doi.org/10.1016/j.chembiol.2006.05.003
Wolfson W. Speed dating for molecules CombinatoRx looks for that special synergy. Chem Biol. 2006 May;13(5):461-2. doi: 10.1016/j.chembiol.2006.05.003. PMID: 16720264.
Copy Download .nbib Format: NLM
Big pharma slims down to bolster productivity.

Nature reviews. Drug discovery

Owens J.
PMID: 17396286
Nat Rev Drug Discov. 2007 Mar;6(3):173-4. doi: 10.1038/nrd2284.

No abstract available.

Cite
Owens J. Big pharma slims down to bolster productivity. Nat Rev Drug Discov. 2007;6(3):173-4doi: 10.1038/nrd2284.
Owens, J. (2007). Big pharma slims down to bolster productivity. Nature reviews. Drug discovery, 6(3), 173-4. https://doi.org/10.1038/nrd2284
Owens, Joanna. "Big pharma slims down to bolster productivity." Nature reviews. Drug discovery vol. 6,3 (2007): 173-4. doi: https://doi.org/10.1038/nrd2284
Owens J. Big pharma slims down to bolster productivity. Nat Rev Drug Discov. 2007 Mar;6(3):173-4. doi: 10.1038/nrd2284. PMID: 17396286.
Copy Download .nbib Format: NLM
Virtual computational chemistry laboratory--design and description.

Journal of computer-aided molecular design

Tetko IV, Gasteiger J, Todeschini R, Mauri A, Livingstone D, Ertl P, Palyulin VA, Radchenko EV, Zefirov NS, Makarenko AS, Tanchuk VY, Prokopenko VV.
PMID: 16231203
J Comput Aided Mol Des. 2005 Jun;19(6):453-63. doi: 10.1007/s10822-005-8694-y.

Internet technology offers an excellent opportunity for the development of tools by the cooperative effort of various groups and institutions. We have developed a multi-platform software system, Virtual Computational Chemistry Laboratory, http://www.vcclab.org, allowing the computational chemist to perform a...

Cite
Tetko IV, Gasteiger J, Todeschini R, et al. Virtual computational chemistry laboratory--design and description. J Comput Aided Mol Des. 2005;19(6):453-63doi: 10.1007/s10822-005-8694-y.
Tetko, I. V., Gasteiger, J., Todeschini, R., Mauri, A., Livingstone, D., Ertl, P., Palyulin, V. A., Radchenko, E. V., Zefirov, N. S., Makarenko, A. S., Tanchuk, V. Y., & Prokopenko, V. V. (2005). Virtual computational chemistry laboratory--design and description. Journal of computer-aided molecular design, 19(6), 453-63. https://doi.org/10.1007/s10822-005-8694-y
Tetko, Igor V, et al. "Virtual computational chemistry laboratory--design and description." Journal of computer-aided molecular design vol. 19,6 (2005): 453-63. doi: https://doi.org/10.1007/s10822-005-8694-y
Tetko IV, Gasteiger J, Todeschini R, Mauri A, Livingstone D, Ertl P, Palyulin VA, Radchenko EV, Zefirov NS, Makarenko AS, Tanchuk VY, Prokopenko VV. Virtual computational chemistry laboratory--design and description. J Comput Aided Mol Des. 2005 Jun;19(6):453-63. doi: 10.1007/s10822-005-8694-y. PMID: 16231203.
Copy Download .nbib Format: NLM
Systematic generation of chemical structures for rational drug design based on QSAR models.

Current computer-aided drug design

Funatsu K, Miyao T, Arakawa M.
PMID: 20550510
Curr Comput Aided Drug Des. 2011 Mar;7(1):1-9. doi: 10.2174/157340911793743556.

The first step in the process of drug development is to determine those lead compounds that demonstrate significant biological activity with regard to a target protein. Because this process is often costly and time consuming, there is a need...

Cite
Funatsu K, Miyao T, Arakawa M. Systematic generation of chemical structures for rational drug design based on QSAR models. Curr Comput Aided Drug Des. 2011;7(1):1-9doi: 10.2174/157340911793743556.
Funatsu, K., Miyao, T., & Arakawa, M. (2011). Systematic generation of chemical structures for rational drug design based on QSAR models. Current computer-aided drug design, 7(1), 1-9. https://doi.org/10.2174/157340911793743556
Funatsu, Kimito, et al. "Systematic generation of chemical structures for rational drug design based on QSAR models." Current computer-aided drug design vol. 7,1 (2011): 1-9. doi: https://doi.org/10.2174/157340911793743556
Funatsu K, Miyao T, Arakawa M. Systematic generation of chemical structures for rational drug design based on QSAR models. Curr Comput Aided Drug Des. 2011 Mar;7(1):1-9. doi: 10.2174/157340911793743556. PMID: 20550510.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 230 entries